Stocks
BridgeBio (BBIO) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -689.9% | -5 646% | -765.7% | -511.9% | -6 078% | -160.8% | ||
| Changes by years, y/y, % | -4 956pp | +4 880pp | +254pp | -5 566pp | +72.3% | ||||
BridgeBio. EBITDA margin, %
BridgeBio. EBITDA margin, changes, pp
BridgeBio (BBIO) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -3 851% | -8 509% | -5.25% | -2 354% | -5 112% | -160.8% | |
| Changes by years, y/y, % | +29 790pp | -2 472pp | +6 436pp | +6 084pp | -1 261pp | |||
| Changes by quarters, q/q, % | +4 587pp | -4 658pp | +8 503pp | -2 349pp | -2 758pp | |||
